Production (Stage)
CannaPharmaRX, Inc.
CPMD
$0.004
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 335.30K | 482.10K | 312.20K | -- | 25.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 335.30K | 482.10K | 312.20K | -- | 25.80K |
| Cost of Revenue | 837.90K | 2.19M | 668.30K | -- | 742.30K |
| Gross Profit | -502.60K | -1.71M | -356.20K | -- | -716.50K |
| SG&A Expenses | 165.10K | -156.30K | 141.80K | 282.30K | 329.70K |
| Depreciation & Amortization | -- | -87.30K | -- | 64.20K | 23.00K |
| Other Operating Expenses | -- | 51.00K | -- | -- | -- |
| Total Operating Expenses | 1.00M | 2.00M | 810.10K | 346.60K | 1.10M |
| Operating Income | -667.70K | -1.52M | -497.90K | -346.60K | -1.07M |
| Income Before Tax | -690.60K | -3.74M | 188.40K | 5.36M | -11.72M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -690.60K | -3.74M | 188.40K | 5.36M | -11.72M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -690.60K | -3.74M | 188.40K | 5.36M | -11.72M |
| EBIT | -667.70K | -1.52M | -497.90K | -346.60K | -1.07M |
| EBITDA | -667.70K | -1.49M | -433.70K | -282.30K | -1.05M |
| EPS Basic | 0.00 | -0.01 | 0.00 | 0.01 | -0.03 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.01 | -0.02 |
| EPS Diluted | 0.00 | -0.01 | 0.00 | 0.01 | -0.03 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.01 | -0.02 |
| Average Basic Shares Outstanding | 662.50M | 662.77M | 662.50M | 657.98M | 350.52M |
| Average Diluted Shares Outstanding | 662.50M | 662.77M | 662.50M | 657.98M | 350.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |